| Followers | 141 |
| Posts | 5785 |
| Boards Moderated | 0 |
| Alias Born | 06/09/2020 |
Tuesday, August 08, 2023 3:22:41 PM
I'm insinuating we very well COULD be much further, in line with LPs wish to trap shorts.
Since ASM almost all rumors regarding partnership, investors and the secret suitor behind the $3M been wrong. Countless sources were correlating these wrongs. Timelines kicked from may to june to july to august to .........
221 days since ASM.
Before fudders rejoice, dream wet dreams and abuse the above - as expected -, mind you I am not one inch deterred from my positive outlook, but I believe by now we have and are being played, retailers and fudders alike.
I sense we could in fact be collectively way off, because that would be in the companys interest in order to be getting max at shorters.
A lot can happen in 221 days, not least if our expectations are kept to the minimum.
"Will we submit soon"?
I believe a lot already has and catalysts have accumulated.
Since ASM almost all rumors regarding partnership, investors and the secret suitor behind the $3M been wrong. Countless sources were correlating these wrongs. Timelines kicked from may to june to july to august to .........
221 days since ASM.
Before fudders rejoice, dream wet dreams and abuse the above - as expected -, mind you I am not one inch deterred from my positive outlook, but I believe by now we have and are being played, retailers and fudders alike.
I sense we could in fact be collectively way off, because that would be in the companys interest in order to be getting max at shorters.
A lot can happen in 221 days, not least if our expectations are kept to the minimum.
"Will we submit soon"?
I believe a lot already has and catalysts have accumulated.
Bullish
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM


